Company registration number 12846706 (England and Wales)
LOUDWATER MED LTD
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
LOUDWATER MED LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
LOUDWATER MED LTD
BALANCE SHEET
AS AT 30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
4
-
0
355
Creditors: amounts falling due within one year
5
(18,479)
(15,967)
Net current liabilities
(18,479)
(15,612)
Capital and reserves
Called up share capital
6
1
1
Profit and loss reserves
(18,480)
(15,613)
Total equity
(18,479)
(15,612)

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 1 April 2026
Mr M Stimler
Director
Company registration number 12846706 (England and Wales)
LOUDWATER MED LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 2 -
1
Accounting policies
Company information

Loudwater Med Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Honeypot House, 56a Crewys Road, London, NW2 2AD.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

These financial statements have been prepared on the assumption that the company will continue in operational existence for the foreseeable future.

The validity of this assumption depends on the continuing support of the director and the parent company.

If the company were unable to continue in existence for the foreseeable future, adjustments would be necessary to reduce the balance sheet values of assets to their recoverable amounts and to provide for further liabilities which might arise.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

LOUDWATER MED LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 3 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

In the director's view, there are no significant judgements or estimates made.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
-
0
355
LOUDWATER MED LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 4 -
5
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
-
0
378
Amounts owed to group undertakings
15,973
13,305
Other creditors
2,506
2,284
18,479
15,967
6
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
1
1
1
1
7
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified.

Senior Statutory Auditor:
A R Gangola FCA
Statutory Auditor:
RDP Newmans LLP
Date of audit report:
8 April 2026
8
Related party transactions

The company has taken advantage of the exemption available in accordance with FRS 102 para 33.1A not to disclose transactions entered into between two or more members of a group, as the company is a wholly owned subsidiary undertaking of the group.

9
Parent company

The company's immediate parent undertaking is Loudwater Trade and Finance Limited, a company incorporated in England and Wales.

The company's ultimate parent undertaking is Loudwater Holdings Ltd, a company registered in England and Wales. The registered office is Honeypot House, 56a Crewys Road, London, NW2 2AD. This is the parent of the largest group of which consolidated financial statements can be prepared, copies of which can be obtained from Companies House.

The ultimate controlling interest is held by Mr M Stimler, by virtue of his majority shareholding in Loudwater Holdings Ltd.

2025-09-30 2024-10-01 false false false 08 April 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr M Stimler 12846706 2024-10-01 2025-09-30 12846706 2025-09-30 12846706 2024-09-30 12846706 core:WithinOneYear 2025-09-30 12846706 core:WithinOneYear 2024-09-30 12846706 core:CurrentFinancialInstruments 2025-09-30 12846706 core:CurrentFinancialInstruments 2024-09-30 12846706 core:ShareCapital 2025-09-30 12846706 core:ShareCapital 2024-09-30 12846706 core:RetainedEarningsAccumulatedLosses 2025-09-30 12846706 core:RetainedEarningsAccumulatedLosses 2024-09-30 12846706 core:ShareCapitalOrdinaryShareClass1 2025-09-30 12846706 core:ShareCapitalOrdinaryShareClass1 2024-09-30 12846706 bus:Director1 2024-10-01 2025-09-30 12846706 2023-10-01 2024-09-30 12846706 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 12846706 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 12846706 bus:OrdinaryShareClass1 2024-10-01 2025-09-30 12846706 bus:OrdinaryShareClass1 2025-09-30 12846706 bus:OrdinaryShareClass1 2024-09-30 12846706 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 12846706 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 12846706 bus:FRS102 2024-10-01 2025-09-30 12846706 bus:Audited 2024-10-01 2025-09-30 12846706 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP